IL17A and metabolic dysfunction-associated steatotic liver disease: Furthermore, IL-23 promotes the expansion and migration of CD4+ T cells in the liver of T2DM with NAFLD, leading to increased IL-17A expression and eventually liver injury [26] (Table 1).